[Purpose] The aim of this study was to determine the frequency, type, and location of pain in hemiplegic patients and the effects on rehabilitation results in our inpatient rehabilitation unit. [Subjects and Methods] Patients rehabilitated between January 2010 and July 2012 were investigated retrospectively. Properties of pain were recorded. Pre- and post-rehabilitation motor evaluation and achievement in daily activities were considered, and differences in scores between groups classified as with and without pain were examined. [Results] The number of patients included in the study was 156. The mean age was 64.28 ± 12.45 years, the mean disease duration was 11.10 months, and the gender distribution was 75 males (48%) and 81 females (52%). Fortysix (29.5%) patients had pain complaints. The nociceptive pain ratio was 86.7%, and the neuropathic pain ratio was 13.3%. Pain was mostly localized at the shoulder joint, with the proportion being 86.9%. In the pain group, statistically significant improvement was found in pain scores after the treatment. There was no significant difference between groups in the pre- and post-rehabilitation Brunnstrom motor evaluation and functional independence measurement scores. [Conclusion] Nociceptive pain is more common than neuropathic pain in patients with hemiplegia, and the shoulder joint is the most frequent location of nociceptive pain.

Bifosfonatların farmakolojik prensibi kemik rezorpsiyonunu suprese etmektir.Bunun için bifosfonatlar osteoporoz tedavisinde yaygın olarak kullanılmaktadır.Kısa dönem kullanım sonrası kemik dansitesini yükselttiği kanıtlansa bile son yayınlarda bifosfanatların uzun dönem kullanımı sonrası femur kırıklarına neden olduğuna dair bilgiler vardır.Biz burada uzun dönem bifosfanat tedavisi almış 73 yaşındaki bayan hastadaki bilateral femur kırığı olgusunu sunduk. (Türk Os te opo roz Dergisi 2012;18: 92-4) Anah tar ke li me ler: Bifosfonat, femur fraktürü Summary Özet Olgu Sunumu / Case Report 92Suppression of bone resorption is the principal pharmacological activity of bisphosphonates. Therefore, bisphosphonates are widely used in the treatment of osteoporosis. Although it has been documented that short-term therapy improves bone density, recent reports indicate that longterm bisphosphonates therapy causes femoral fractures. We present a case of bilateral femoral fracture in 73 years old female patient on longterm bisphosphonates therapy. (Turkish Journal of Osteoporosis 2012;18: 92-4)

No abstract

Aim: Fibromyalgia is a disease that is characterized by chronic widespread musculoskeletal pain, sleep disorders, fatigue and decreased pain threshold. The purpose of our study was to investigate the effect of physiotherapy on pain, depression and neck functions in patients with chronic cervical disc hernia accompanied by fibromyalgia. Materials and Methods:In total, 20 chronic cervical disc hernia patients who were diagnosed with fibromyalgia according to the 2010 American College of Rheumatology diagnostic criteria and 20 chronic cervical disc hernia patients without fibromyalgia were included in our study. Visual analogue scale (VAS), Beck depression inventory (BDI), and neck disability index (NDI) were performed to evaluate pain, depression and neck functions respectively. Patients were evaluated before therapy, immediately after therapy, and at 1-month control follow-up. Results:In both groups, VAS, BDI and NDI scores were significantly decreased in the period after therapy and at 1-month control follow-up compared to the pre-treatment period. No statistical difference was observed between two groups in terms of VAS, BDI and NDI scores before and after treatment. However, we found that VAS, BDI and NDI scores of cervical disc hernia patients with fibromyalgia were significantly higher than cervical disc hernia patients without fibromyalgia before treatment, after treatment and at 1-month control follow-up. Conclusion:We demonstrated that the effect of physical therapy on pain, depression, and neck function was the same in the group with fibromyalgia compared to the group without fibromyalgia.

SUMMARY OBJECTIVE: Fibromyalgia is one of the most important problems, especially for women. Studies point to disorders in the sexual functions of fibromyalgia patients that reduce their quality of life. The aim of this study was to investigate sexual dysfunction and its relationship with disease severity and depression in women with fibromyalgia. METHODS: This study included 98 female patients diagnosed with fibromyalgia and 54 healthy women. The Female Sexual Function Index was used to assess sexual dysfunction. Fibromyalgia disease severity was measured with the Fibromyalgia Impact Questionnaire. Hamilton Depression Scale was filled in to evaluate the depression status of the patients. RESULTS: According to the female sexual function index data, female sexual dysfunction was found in 78 (79.6%) patients with fibromyalgia and only in 12 (22.2%) controls. When the female sexual function index scores of fibromyalgia patients with and without depression were compared, patients with additional depression had lower female sexual function index scores, and this difference was statistically significant (p=0.002). In the correlation analysis, the female sexual function index score showed a significant negative correlation with the hamilton depression scale (rho=-0.235, p=0.020) and fibromyalgia impact questionnaire (rho=-0.215, p=0.033) scores. CONCLUSION: This study highlights the high prevalence of sexual dysfunction in female fibromyalgia patients and the significant correlation between sexual dysfunction and both disease severity and depression.